ABSTRACT SUBMISSION
General instructions
Deadline for abstract submission extended to March 16, 2009.
Participants who want to attend both, the Pre-satellite Meeting as well as the PharmSciFair can submit the same abstract twice. In this case, please: (i) register and submit the abstract for the Pre-satellite Meeting and, (ii) register and submit the abstract for the PharmSciFair.
Please note that only one abstract can be submitted per participant for the Pre-satellite Meeting.
Please click here to download the abstract form
The abstract should be sent to: apgi.asso@u-psud.fr
Notification on acceptance
(and day for presentation) of the
abstracts will be emailed to the
contact person in March 2009. The
corresponding author will receive
all correspondence concerning
the abstract. The corresponding
author is responsible for informing
the other authors of the status of
the abstract.
It is the author’s responsibility
to submit a correct abstract; any
errors in spelling, grammar, or
scientific facts will be reproduced
as typed by the author.
Specifics
• Abstracts must be written in English.
• Write the title in lower case letters.
• Maximum 200 words (1400 characters including spaces but excluding the title and the authors).
• Make the abstract as informative as possible, including a brief statement of the purpose of the study, the method used, the result obtained,
and the conclusion based upon the result.
• The following information is requested for all authors: initial(s) for first name, family name(s), institution, department, city and country.
• One author must be marked as the presenting author on the online submission form.
• Double space between paragraphs and before the list of references.
• Key reference should be stated under the body text of the abstract.
Domains and keywords
When submitting an abstract, please indicate a session from the list below:
Session list
as well as 3 keywords from the list below:
Keywords list
| Absorption enhancement ADME ADMET Aerosol Alternative methods Analysis Animal models Antibodies Anti-cancer agents Automation Batches for clinical trials Beads Bioanalysis Bioassays Bioavailability Biobanks Biocompatibility Bioequivalence Biofluid analysis Biogenerics Biology Biomarkers Biomarker analysis Biomaterials Biopharmaceuticals Biopharmaceutics Biosimilars Biowaivers Blood brain barrier Blood substitutes Brain delivery Cell cultures Chemometrics Chip-based analysis Clinical drug candidate Clinical practice Clinical trialsCrystallisation Compaction Computational methods |
Controlled release |
Growth factors |
Nanoscience |
Proteomics |